News Survey reveals heavy burden of chronic hand eczema People with chronic hand eczema (CHE) have reported the serious impact the condition can have on their daily lives in a UK survey.
Healthcare The end-of-life care conundrum Research advises against aggressive cancer treatment at the end-of-life stages of the disease.
Views & Analysis Why should pharma invest in digital products for those livin... Each person living with a rare disease has a unique experience of their condition, but all will have faced similar challenges.
Views & Analysis Quality of life increasingly important in skin cancer, say d... The factors a doctor should consider when choosing between therapies that could cure patients with skin cancer proved a major talking point at an event on the fringes of this year’s ESMO conference
Views & Analysis Value-based healthcare: What’s it worth to you? It takes healthy people to make a healthy society – and that must be taken into account when we are talking about value-based healthcare.
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
